These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 30668434

  • 1. Curcumin potentiates the antitumor activity of Paclitaxel in rat glioma C6 cells.
    Fratantonio D, Molonia MS, Bashllari R, Muscarà C, Ferlazzo G, Costa G, Saija A, Cimino F, Speciale A.
    Phytomedicine; 2019 Mar 01; 55():23-30. PubMed ID: 30668434
    [Abstract] [Full Text] [Related]

  • 2. Synergistic Anti-glioma Effects in Vitro and in Vivo of Enediyne Antibiotic Neocarzinostatin and Paclitaxel via Enhanced Growth Delay and Apoptosis-Induction.
    Tianqin G, Chunlei C, Jingjing W.
    Biol Pharm Bull; 2016 Oct 01; 39(10):1623-1630. PubMed ID: 27431785
    [Abstract] [Full Text] [Related]

  • 3. Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-κB pathways.
    Allegra A, Speciale A, Molonia MS, Guglielmo L, Musolino C, Ferlazzo G, Costa G, Saija A, Cimino F.
    Toxicol In Vitro; 2018 Mar 01; 47():186-194. PubMed ID: 29223572
    [Abstract] [Full Text] [Related]

  • 4. Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy.
    Ruttala HB, Ko YT.
    Colloids Surf B Biointerfaces; 2015 Apr 01; 128():419-426. PubMed ID: 25797481
    [Abstract] [Full Text] [Related]

  • 5. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor.
    Yu LL, Wu JG, Dai N, Yu HG, Si JM.
    Oncol Rep; 2011 Nov 01; 26(5):1197-203. PubMed ID: 21811763
    [Abstract] [Full Text] [Related]

  • 6. Pygopus2 inhibits the efficacy of paclitaxel-induced apoptosis and induces multidrug resistance in human glioma cells.
    Zhou C, Cheng H, Qin W, Zhang Y, Xiong H, Yang J, Huang H, Wang Y, Chen XZ, Tang J.
    Oncotarget; 2017 Apr 25; 8(17):27915-27928. PubMed ID: 28427190
    [Abstract] [Full Text] [Related]

  • 7. Antitumor efficacy of a novel CLA-PTX microemulsion against brain tumors: in vitro and in vivo findings.
    Li D, Yang K, Li JS, Ke XY, Duan Y, Du R, Song P, Yu KF, Ren W, Huang D, Li XH, Hu X, Zhang X, Zhang Q.
    Int J Nanomedicine; 2012 Apr 25; 7():6105-14. PubMed ID: 23269869
    [Abstract] [Full Text] [Related]

  • 8. The therapeutic efficacy of conjugated linoleic acid - paclitaxel on glioma in the rat.
    Ke XY, Zhao BJ, Zhao X, Wang Y, Huang Y, Chen XM, Zhao BX, Zhao SS, Zhang X, Zhang Q.
    Biomaterials; 2010 Aug 25; 31(22):5855-64. PubMed ID: 20430438
    [Abstract] [Full Text] [Related]

  • 9. Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma.
    Liu E, Wu J, Cao W, Zhang J, Liu W, Jiang X, Zhang X.
    J Neurooncol; 2007 Dec 25; 85(3):263-70. PubMed ID: 17594054
    [Abstract] [Full Text] [Related]

  • 10. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
    Di Mauro PP, Cascante A, Brugada Vilà P, Gómez-Vallejo V, Llop J, Borrós S.
    Int J Pharm; 2018 Dec 20; 553(1-2):169-185. PubMed ID: 30321641
    [Abstract] [Full Text] [Related]

  • 11. Curcumin suppresses cell growth and invasion and induces apoptosis by down-regulation of Skp2 pathway in glioma cells.
    Wang L, Ye X, Cai X, Su J, Ma R, Yin X, Zhou X, Li H, Wang Z.
    Oncotarget; 2015 Jul 20; 6(20):18027-37. PubMed ID: 26046466
    [Abstract] [Full Text] [Related]

  • 12. Curcumin and paclitaxel induce cell death in breast cancer cell lines.
    Calaf GM, Ponce-Cusi R, Carrión F.
    Oncol Rep; 2018 Oct 20; 40(4):2381-2388. PubMed ID: 30066930
    [Abstract] [Full Text] [Related]

  • 13. Bexarotene inhibits cell proliferation by inducing oxidative stress, DNA damage and apoptosis via PPARγ/ NF-κB signaling pathway in C6 glioma cells.
    Hacioglu C, Kar F, Kacar S, Sahinturk V, Kanbak G.
    Med Oncol; 2021 Feb 18; 38(3):31. PubMed ID: 33599853
    [Abstract] [Full Text] [Related]

  • 14. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
    Sreekanth CN, Bava SV, Sreekumar E, Anto RJ.
    Oncogene; 2011 Jul 14; 30(28):3139-52. PubMed ID: 21317920
    [Abstract] [Full Text] [Related]

  • 15. Metformin enhances antitumor action of sodium dichloroacetate against glioma C6.
    Kolesnik DL, Pyaskovskaya ON, Yurchenko OV, Solyanik GI.
    Exp Oncol; 2019 Jun 14; 41(2):123-129. PubMed ID: 31262158
    [Abstract] [Full Text] [Related]

  • 16. Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects.
    Ashrafizadeh M, Zarrabi A, Hashemi F, Moghadam ER, Hashemi F, Entezari M, Hushmandi K, Mohammadinejad R, Najafi M.
    Life Sci; 2020 Sep 01; 256():117984. PubMed ID: 32593707
    [Abstract] [Full Text] [Related]

  • 17. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
    Alemi A, Zavar Reza J, Haghiralsadat F, Zarei Jaliani H, Haghi Karamallah M, Hosseini SA, Haghi Karamallah S.
    J Nanobiotechnology; 2018 Mar 23; 16(1):28. PubMed ID: 29571289
    [Abstract] [Full Text] [Related]

  • 18. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
    Tian F, Fan T, Zhang Y, Jiang Y, Zhang X.
    Acta Biochim Biophys Sin (Shanghai); 2012 Oct 23; 44(10):847-55. PubMed ID: 23017833
    [Abstract] [Full Text] [Related]

  • 19. Combined Delivery and Anti-Cancer Activity of Paclitaxel and Curcumin Using Polymeric Micelles.
    Gao X, Wang B, Wu Q, Wei X, Zheng F, Men K, Shi H, Huang N, Wei Y, Gong C.
    J Biomed Nanotechnol; 2015 Apr 23; 11(4):578-89. PubMed ID: 26310065
    [Abstract] [Full Text] [Related]

  • 20. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z, Xie G, Zhou G, Cheng Y, Zhang G, Yao G, Chen Y, Li Y, Zhao G.
    Cancer Lett; 2015 Oct 10; 367(1):58-68. PubMed ID: 26188279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.